T 0206/19 (Protease resistant insulin/NOVO NORDISK) of 05.10.2021
- European Case Law Identifier
- ECLI:EP:BA:2021:T020619.20211005
- Date of decision
- 5 October 2021
- Case number
- T 0206/19
- Petition for review of
- -
- Application number
- 07820423.7
- IPC class
- C07K 14/62A61K 38/28C12N 15/17
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Protease resistant insulin analogues
- Applicant name
- Novo Nordisk A/S
- Opponent name
- Eli Lilly and Company
- Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(2)Rules of procedure of the Boards of Appeal Art 12(4)
- Keywords
- Late-filed requests (AR6, AR5, AR5(b), AR3, AR3(b), AR4, AR4(b))
Late-filed request - submitted with the statement of grounds of appeals
Late-filed request - requests could have been filed in first instance proceedings (yes)
Amendments (AR7, AR7(b))
Amendments - extension beyond the content of the application as filed (yes) - Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
The appeal is dismissed.